Diagnomics
Signal active
Organization
Contact Information
Overview
Diagnomics operates as a Next Generation Sequencing (NGS)-based genomics company. Diagnomics’ mission is to provide sophisticated solutions for personalized medicine and next generation healthcare. Diagnomics offers high quality innovative R&D and CLIA services to global pharmaceutical, biotech and medical device companies as well as academic institutions.
About
Industries
Biotechnology, Medical
Founded
2011
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Diagnomics headquartered in United States, North America, operates in the Biotechnology, Medical sector. With a team of 1-10 employees, Diagnomics is actively contributing to advancements in Biotechnology. Their latest funding round, Corporate Round - Diagnomics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$0
Details
0
Diagnomics has raised a total of $0 in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Diagnomics is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Diagnomics | - | FUNDING ROUND - Diagnomics | undefined |
| Oncology Pharma | - | FUNDING ROUND - Oncology Pharma | undefined |
Recent Activity
There is no recent news or activity for this profile.